4//SEC Filing
Edwards Lifesciences Corp 4
Accession 0001225208-13-004989
$EWCIK 0001099800operating
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 4:45 PM ET
Size
9.0 KB
Accession
0001225208-13-004989
Insider Transaction Report
Form 4
KEHL JOHN H JR
CVP, Strategy & Corp Dev
Transactions
- Exercise/Conversion
Common Stock
2013-02-20$21.95/sh+12,500$274,438→ 115,178 total - Sale
Common Stock
2013-02-20$86.60/sh−12,500$1,082,500→ 102,678 total - Exercise/Conversion
Employee Stock Option (Right to Acquire)
2013-02-20−12,500→ 25,000 totalExercise: $21.95From: 2007-05-11Exp: 2013-05-10→ Common Stock (12,500 underlying)
Footnotes (3)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 28, 2012.
- [F2]This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.
- [F3]This transaction was executed in multiple trades at prices ranging from $86.32 to $86.91. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Edwards Lifesciences Corp
CIK 0001099800
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001099800
Filing Metadata
- Form type
- 4
- Filed
- Feb 20, 7:00 PM ET
- Accepted
- Feb 21, 4:45 PM ET
- Size
- 9.0 KB